Continuous monitoring of API content, API distribution and crushing strength after tableting via near-infrared chemical imaging

P. R. Wahl, I. Pucher, O. Scheibelhofer, M. Kerschhaggl, S. Sacher, J. G. Khinast

Research output: Contribution to journalArticleResearchpeer-review

Original languageEnglish
Pages (from-to)130-137
JournalInternational Journal of Pharmaceutics
Volume518
Issue number1-2
DOIs
Publication statusPublished - 25 Feb 2017

Keywords

  • Near-infrared spectroscopy (NIR)
  • Chemical imaging
  • Tableting
  • Process analytical technology (PAT)
  • Homogeneity

Cite this

Continuous monitoring of API content, API distribution and crushing strength after tableting via near-infrared chemical imaging. / Wahl, P. R.; Pucher, I.; Scheibelhofer, O.; Kerschhaggl, M.; Sacher, S.; Khinast, J. G.

In: International Journal of Pharmaceutics, Vol. 518, No. 1-2, 25.02.2017, p. 130-137.

Research output: Contribution to journalArticleResearchpeer-review

@article{36ca7954b6e44f7db4f8c3d0829c91ef,
title = "Continuous monitoring of API content, API distribution and crushing strength after tableting via near-infrared chemical imaging",
keywords = "Near-infrared spectroscopy (NIR), Chemical imaging, Tableting, Process analytical technology (PAT), Homogeneity",
author = "Wahl, {P. R.} and I. Pucher and O. Scheibelhofer and M. Kerschhaggl and S. Sacher and Khinast, {J. G.}",
year = "2017",
month = "2",
day = "25",
doi = "10.1016/j.ijpharm.2016.12.003",
language = "English",
volume = "518",
pages = "130--137",
journal = "International Journal of Pharmaceutics",
issn = "0378-5173",
publisher = "Elsevier B.V.",
number = "1-2",

}

TY - JOUR

T1 - Continuous monitoring of API content, API distribution and crushing strength after tableting via near-infrared chemical imaging

AU - Wahl, P. R.

AU - Pucher, I.

AU - Scheibelhofer, O.

AU - Kerschhaggl, M.

AU - Sacher, S.

AU - Khinast, J. G.

PY - 2017/2/25

Y1 - 2017/2/25

KW - Near-infrared spectroscopy (NIR)

KW - Chemical imaging

KW - Tableting

KW - Process analytical technology (PAT)

KW - Homogeneity

U2 - 10.1016/j.ijpharm.2016.12.003

DO - 10.1016/j.ijpharm.2016.12.003

M3 - Article

VL - 518

SP - 130

EP - 137

JO - International Journal of Pharmaceutics

JF - International Journal of Pharmaceutics

SN - 0378-5173

IS - 1-2

ER -